Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFE SCIENCES   TEVA PHARMA
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-23
TEVA PHARMA
Dec-13
SUVEN LIFE SCIENCES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs943,479-   
Low Rs453,022-   
Sales per share (Unadj.) Rs0.61,996.4-  
Earnings per share (Unadj.) Rs-5.4124.7-  
Cash flow per share (Unadj.) Rs-5.1286.1-  
Dividends per share (Unadj.) Rs0109.18-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs17.22,217.6-  
Shares outstanding (eoy) m218.07848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x111.81.6 6,864.5%   
Avg P/E ratio x-12.826.1 -49.1%  
P/CF ratio (eoy) x-13.511.4 -119.2%  
Price / Book Value ratio x4.01.5 275.1%  
Dividend payout %087.5 -0.0%   
Avg Mkt Cap Rs m15,1312,756,220 0.5%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m1860-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m1351,692,969 0.0%  
Other income Rs m840-   
Total revenues Rs m2201,692,969 0.0%   
Gross profit Rs m-1,196463,620 -0.3%  
Depreciation Rs m65136,844 0.0%   
Interest Rs m533,253 0.0%   
Profit before tax Rs m-1,183293,523 -0.4%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m0-3,584 -0.0%   
Profit after tax Rs m-1,183105,758 -1.1%  
Gross profit margin %-883.627.4 -3,226.7%  
Effective tax rate %0-1.2 0.0%   
Net profit margin %-873.56.2 -13,983.4%  
BALANCE SHEET DATA
Current assets Rs m3,4551,143,425 0.3%   
Current liabilities Rs m1,050997,163 0.1%   
Net working cap to sales %1,776.08.6 20,557.4%  
Current ratio x3.31.1 286.9%  
Inventory Days Days3,94891 4,348.6%  
Debtors Days Days21896 226.9%  
Net fixed assets Rs m1,373552,961 0.2%   
Share capital Rs m2184,167 5.2%   
"Free" reserves Rs m3,5350-   
Net worth Rs m3,7531,880,567 0.2%   
Long term debt Rs m0865,653 0.0%   
Total assets Rs m4,8283,868,976 0.1%  
Interest coverage x-218.89.8 -2,226.8%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x00.4 6.4%   
Return on assets %-24.43.6 -678.7%  
Return on equity %-31.55.6 -560.3%  
Return on capital %-31.44.9 -636.1%  
Exports to sales %40.40-   
Imports to sales %839.80-   
Net fx Rs m-1,0820-   
CASH FLOW
From Operations Rs m-1,031269,772 -0.4%  
From Investments Rs m-2,606-95,591 2.7%  
From Financial Activity Rs m3,955-323,609 -1.2%  
Net Cashflow Rs m317-149,429 -0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare SUVEN LIFE SCIENCES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare SUVEN LIFE SCIENCES With: BAL PHARMA  ZOTA HEALTH CARE  SMRUTHI ORGANICS  AARTI PHARMALABS  EARUM PHARMACEUTICALS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.